info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_STOMACH_ADENO_EXALLC for full statistics.

Adenocarcinoma and papillary adenocarcinoma of stomach

C3_STOMACH_ADENO

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Cancer registry: Topography ICD-O-3 C16
Cancer registry: Morphology ICD-O-3 8140|8145
Cancer registry: Behaviour codes 3

1 out of 7 registries used, show all original rules.

772

diagram downward connector

Check minimum number of events None

772

diagram downward connector

Include endpoints None

772

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

737

diagram downward connector
C3_STOMACH_ADENO

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF8

Similar endpoints

List of similar endpoints to Adenocarcinoma and papillary adenocarcinoma of stomach based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 737 196 541
Unadjusted prevalence (%) 0.20 0.09 0.33
Mean age at first event (years) 67.01 63.20 68.39

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: C3_STOMACH_ADENO – Adenocarcinoma and papillary adenocarcinoma of stomach
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Adenocarcinoma and papillary adenocarcinoma of stomach

Endpoint not on priority list, no data to show.